2009 journal article

Efficacy and tolerability of once-daily budesonide/formoterol pressurized metered-dose inhaler in adults and adolescents with asthma previously stable with twice-daily budesonide/formoterol dosing

ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 103(1), 62–72.

By: E. Kerwin, J. Oppenheimer, C. LaForce*, B. Parasuraman, C. Miller, L. O'Dowd, M. Goldman

MeSH headings : Adolescent; Adult; Aged; Asthma / drug therapy; Asthma / physiopathology; Bronchodilator Agents / administration & dosage; Bronchodilator Agents / adverse effects; Bronchodilator Agents / therapeutic use; Budesonide / administration & dosage; Budesonide / adverse effects; Budesonide / therapeutic use; Child; Double-Blind Method; Drug Combinations; Ethanolamines / administration & dosage; Ethanolamines / adverse effects; Ethanolamines / therapeutic use; Female; Forced Expiratory Volume / physiology; Formoterol Fumarate; Humans; Male; Metered Dose Inhalers; Middle Aged; Patient Satisfaction; Peak Expiratory Flow Rate / physiology; Quality of Life; Surveys and Questionnaires; Treatment Outcome; Young Adult
UN Sustainable Development Goal Categories
Source: Web Of Science
Added: August 6, 2018

Citation Index includes data from a number of different sources. If you have questions about the sources of data in the Citation Index or need a set of data which is free to re-distribute, please contact us.

Certain data included herein are derived from the Web of Science© and InCites© (2024) of Clarivate Analytics. All rights reserved. You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.